5′ adenosine monophosphate-activated protein kinase, metabolism and exercise

被引:54
作者
Aschenbach, WG
Sakamoto, K
Goodyear, LJ
机构
[1] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.2165/00007256-200434020-00003
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The 5' adenosine monophosphate-activated protein kinase (AMPK) is a member of a metabolite-sensing protein kinase family that functions as a metabolic 'fuel gauge' in skeletal muscle. AMPK is a ubiquitous heterotrimeric protein, consisting of an a catalytic, and beta and gamma regulatory subunits that exist in multiple isoforms and are all required for full enzymatic activity. During exercise, AMPK becomes activated in skeletal muscle in response to changes in cellular energy status (e.g. increased adenosine monophosphate [AMP]/adenosine triphosphate [ATP] and creatine/phosphocreatine ratios) in an intensity-dependent manner, and serves to inhibit ATP-consuming pathways, and activate pathways involved in carbohydrate and fatty-acid metabolism to restore ATP levels. Recent evidence shows that although AMPK plays this key metabolic role during acute bouts of exercise, it is also an important component of the adaptive response of skeletal muscles to endurance exercise training because of its ability to alter muscle fuel reserves and expression of several exercise-responsive genes. This review discusses the putative roles of AMPK in acute and chronic exercise responses, and suggests avenues for future AMPK research in exercise physiology and biochemistry.
引用
收藏
页码:91 / 103
页数:13
相关论文
共 89 条
  • [1] Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle
    Ai, H
    Ihlemann, J
    Hellsten, Y
    Lauritzen, HPMM
    Hardie, DG
    Galbo, H
    Ploug, T
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (06): : E1291 - E1300
  • [2] Effect of AICAR treatment on glycogen metabolism in skeletal muscle
    Aschenbach, WG
    Hirshman, MF
    Fujii, N
    Sakamoto, K
    Howlett, KF
    Goodyear, LJ
    [J]. DIABETES, 2002, 51 (03) : 567 - 573
  • [3] Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats
    Bergeron, R
    Previs, SF
    Cline, GW
    Perret, P
    Russell, RR
    Young, LH
    Shulman, GI
    [J]. DIABETES, 2001, 50 (05) : 1076 - 1082
  • [4] Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
    Bergeron, R
    Ren, JM
    Cadman, KS
    Moore, IK
    Perret, P
    Pypaert, M
    Young, LH
    Semenkovich, CF
    Shulman, GI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (06): : E1340 - E1346
  • [5] Effect of AMPK activation on muscle glucose metabolism in conscious rats
    Bergeron, R
    Russell, RR
    Young, LH
    Ren, JM
    Marcucci, M
    Lee, A
    Shulman, GI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (05): : E938 - E944
  • [6] Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase
    Beyer, A
    Kitzerow, A
    Crute, B
    Kemp, BE
    Witters, LA
    Heilmeryer, LMG
    [J]. BIOLOGICAL CHEMISTRY, 2000, 381 (5-6) : 457 - 461
  • [7] Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
    Blair, E
    Redwood, C
    Ashrafian, H
    Oliveira, M
    Broxholme, J
    Kerr, B
    Salmon, A
    Östman-Smith, I
    Watkins, H
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (11) : 1215 - 1220
  • [8] AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
    Bolster, DR
    Crozier, SJ
    Kimball, SR
    Jefferson, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 23977 - 23980
  • [9] Brooks GA., 2000, Exercise Physiology: Human Bioenergetics and its Applications, V3rd
  • [10] Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner
    Buhl, ES
    Jessen, N
    Schmitz, O
    Pedersen, SB
    Pedersen, O
    Holman, GD
    Lund, S
    [J]. DIABETES, 2001, 50 (01) : 12 - 17